What You Should Know:
– Abridge, a provider of generative AI solutions for healthcare, today announced a $250M Series D funding round, bringing its total capital raised to over $425M.
– The investment, co-led by Elad…
Continue Reading
Abridge, a generative AI platform for clinical conversations, announced it raised a $250 million Series D investment.The round was co-led by Elad Gil and IVP, with participation from Bessemer Venture Partners, California Health Care…
Continue Reading
What You Should Know:
– Suki, a provider of artificial intelligence (AI) technology for healthcare, announced a strategic investment from Zoom Ventures, the investment arm of Zoom Communications, Inc.
– the investment builds upon Suki’s recent…
Continue Reading
We are only two weeks into 2025, and a small handful of healthcare AI companies have already announced funding rounds exceeding $100 million — signaling a strong start to what investors predicted would be…
Continue Reading
Qventus, which offers health systems an AI-based care automation platform, has garnered $105 million in Series D funding in a round led by KKR. Bessemer Venture Partners also participated in the round alongside new strategic…
Continue Reading
This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in December. Here is…
Continue Reading
ŌURA, a wearable device company, has secured $200 million in Series D funding to expand its product offerings, the company announced last week.
ŌURA, which was founded in Finland in 2013, offers a wearable smart…
Continue Reading
Health-tracking ring maker Oura announced it closed a $200 million Series D funding round led by Fidelity Management & Research Company and Dexcom. The investment raises the company’s valuation to $5.2 billion.WHAT IT DOES
The…
What You Should Know:
– ŌURA, the company behind the world’s leading smart ring, has announced the completion of a $200 million Series D funding round, raising its valuation to $5.2B.
– This significant investment, with…
Continue Reading
Glucose-monitoring specialist Dexcom announced it has made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow between Dexcom’s continuous glucose monitor (CGM) and…
Continue Reading
